Suchergebnisse - "Biological Factors"

PubPharm (435)

1

Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease : a cohort study from the German RABBIT register

enthalten in: RMD open | 2024

von Rudi, T. | Zietemann, V. | Meissner, Y. | +6

2

Adverse events of biological agents in pediatric rheumatologic diseases

enthalten in: Postgraduate medicine | 2024

von Polat, M. | Mertek, S. | Özçakar, Z. | +6

3

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis

enthalten in: Clinical pharmacokinetics | 2024

von Greenzaid, J. | Feldman, S.

4

The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database : a 5-year follow-up study

enthalten in: Rheumatology (Oxford, England) | 2023

von Yagiz, B. | Lermi, N. | Coskun, B. | +22

5

Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis

enthalten in: Modern rheumatology | 2023

von Yamasaki, Y. | Nakamura, A. | Kubota, T. | +4

6

Tackling TNF-α in autoinflammatory disorders and autoimmune diseases : From conventional to cutting edge in biologics and RNA- based nanomedicines

enthalten in: Advanced drug delivery reviews | 2023

von Andretto, V. | Dusi, S. | Zilio, S. | +4

7

Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease

enthalten in: Drugs | 2023

von Gisbert, J. | Chaparro, M.

8

Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure : A Real-World Propensity Score-Weighted Analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Ibing, S. | Cho, J. | Böttinger, E. | +1

9

Persistence Among Patients with Crohn Disease Previously Treated with an Anti-tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic Agent

enthalten in: Clinical therapeutics | 2023

von Zhdanava, M. | Kachroo, S. | Manceur, A. | +5

10

Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease

enthalten in: Digestive diseases and sciences | 2023

von Eriksson, C. | Söderling, J. | Karlqvist, S. | +7

CommentIn: Dig Dis Sci. 2023 Jul;68(7):2785-2786. - PMID 37024738

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[44]